Email Updates

Search form

You are here

Partners Demonstration Project

Status
Ongoing
Phase
Demo Project
Principal Investigator(s)
Led by a team of scientists from Kenya, Uganda and the US
Objective

Evaluates HIV prevention preferences among approximately 1,000 HIV serodiscordant couples, adherence to PrEP and ART and interface of reproductive health priorities and ART-based prevention. Will implement PrEP as “bridge” to ART, providing PrEP to HIV-negative partner when HIV-positive partner is not yet on ART due to ineligibility based on country guidelines or personal decision.

**Preliminary results presented Feb 2015 show the use of PrEP reduced the risk of HIV infection by 96 percent.**
Prevention Option(s)
PrEP
Trial Sponsors
NIMH/NIH, USAID and BMGF
August 2013
December 2016
Enrollment
2 000
18
Population
Women
Men
Serodiscordant
Sites

Site(s) - Kenya

Kenya

Site(s) - Uganda

Uganda